Article
RB1 Genetic Alterations in Estrogen Receptor-Positive Breast Carcinomas: Correlation With Neuroendocrine Differentiation.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Aug 2024
Schwartz Christopher J, Marra Antonio, Selenica Pier, Gazzo Andrea, Tan Kiki, Ross Dara, Razavi Pedram, Chandarlapaty Sarat, Weigelt Britta, Reis-Filho Jorge S, Brogi Edi, Pareja Fresia, Wen Hannah Y
Abstract excerpt
Genetic alterations in the retinoblastoma susceptibility gene (RB1) are present in up to 40% of triple-negative breast cancers (BCs) and frequent in tumors with neuroendocrine differentiation, including small cell neuroendocrine carcinoma. Data on RB1 genetic alterations in estrogen receptor (ER)-positive BCs are scarce. In this study, we sought to define the morphologic, immunohistochemical, and genetic features...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
